The incidence of prophylaxis failure with letermovir , as compared with placebo , was 48 % versus 64 % at a daily letermovir dose of 60 mg ( P = 0.32 ) , 32 % at a dose of 120 mg ( P = 0.01 ) , and 29 % at a dose of 240 mg ( P = 0.007 ) .